Celularity (CELU) Net Margin (2020 - 2025)
Celularity's (CELU) quarterly Net Margin came in at 594.23% in Q4 2025, up 133761.0% year-over-year from N/an in Q4 2024, and down 36.08% quarter-over-quarter from 436.66% in Q3 2025.
Powered by 
Analysis
Celularity (CELU) Net Margin (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Net Margin for 6 consecutive years, with 594.23% the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Margin rose 133761.0% year-over-year to 594.23% in Q4 2025; TTM through Dec 2025 was 345.76%, a 18834.0% decrease from a year earlier, with the FY2025 full-year figure at 345.76%, down 23899.0% from the prior year.
- Net Margin was 594.23% for Q4 2025 at Celularity, down from 436.66% in the prior quarter.
- Over five years, Net Margin peaked at 1266.58% in Q2 2022 and troughed at 3063.73% in Q1 2021.
- A 5-year average of 668.99% and a median of 300.5% in 2025 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 328474 bps in 2022 and plunged 289861 bps in 2023, its largest moves.
- Over 5 years, Net Margin stood at 83.2% in 2021, then surged by 811 bps to 591.77% in 2022, then sank by 87 bps to 78.82% in 2023, then sank by 2551 bps to 1931.83% in 2024, then jumped by 69 bps to 594.23% in 2025.
- The last three Net Margin figures came in at 594.23% (Q4 2025), 436.66% (Q3 2025), and 427.6% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 45.94% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -895.73% |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | -47.62% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 20.08% |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -1,387.76% |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | -25,036.33% |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 36.51% |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -1.22% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 2.88% |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | -594.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -594.23% |
| Sep 30, 2025 | -436.66% |
| Jun 30, 2025 | -427.60% |
| Mar 31, 2025 | -173.40% |
| Dec 31, 2024 | -1,931.83% |
| Sep 30, 2024 | -173.19% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 78.82% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,632.03% |
| Mar 31, 2023 | -1,626.86% |
| Dec 31, 2022 | 591.77% |
| Sep 30, 2022 | 116.06% |
| Jun 30, 2022 | 1,266.58% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -83.20% |
| Sep 30, 2021 | 470.14% |
| Jun 30, 2021 | -2,018.16% |
| Mar 31, 2021 | -3,063.73% |